Department of Periodical Press and National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, 610041 Sichuan, China.
Department of Clinical Medicine, Gansu University of Traditional Chinese Medicine, Lanzhou 730020, China.
J Diabetes Res. 2020 Sep 11;2020:5767582. doi: 10.1155/2020/5767582. eCollection 2020.
The objective of this study was to analyze the 100 top-cited systematic reviews/meta-analyses on diabetic research.
The Science Citation Index Expanded database was searched to identify top-cited studies on diabetic research up to March 4, 2020. Studies were analyzed using the following characteristics: citation number, publication year, country and institution of origin, authorship, topics, and journals.
The 100 top-cited diabetic systematic reviews/meta-analyses were published in 43 different journals, with having the highest numbers ( = 17), followed by ( = 14) and ( = 9). The majority of studies are published in the 2000s. The number of citations ranged from 2197 to 301. The highest number of contributions was from the USA, followed by England and Australia. The leading institution was Harvard University. The hot topic was a risk factor ( = 33), followed by comorbidity ( = 27).
The 100 top-cited systematic reviews/meta-analyses on diabetic research identify impactful authors, journals, institutes, and countries. It will also provide the most important references to evidence-based medicine in diabetes and serve as a guide to the features of a citable paper in this field.
本研究旨在分析糖尿病研究领域的 100 篇高被引系统评价/荟萃分析。
检索科学引文索引扩展数据库，以确定截至 2020 年 3 月 4 日的糖尿病研究高被引研究。使用以下特征分析研究：引用数量、出版年份、来源国家和机构、作者、主题和期刊。
100 篇高被引糖尿病系统评价/荟萃分析发表在 43 种不同的期刊上，其中《Diabetes Care》（= 17）最高，其次是《Diabetes》（= 14）和《JAMA》（= 9）。大多数研究发表于 21 世纪。引用数量从 2197 到 301 不等。贡献最多的国家是美国，其次是英国和澳大利亚。领先的机构是哈佛大学。热门主题是风险因素（= 33），其次是合并症（= 27）。
糖尿病研究的 100 篇高被引系统评价/荟萃分析确定了有影响力的作者、期刊、机构和国家。它还将为糖尿病循证医学提供最重要的参考文献，并作为该领域有影响力论文特征的指南。
